GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » DeferredTaxAndRevenue

ANL (Adlai Nortye) DeferredTaxAndRevenue : $5.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Adlai Nortye's current deferred tax and revenue for the quarter that ended in Dec. 2024 was $5.00 Mil.

Adlai Nortye DeferredTaxAndRevenue Historical Data

The historical data trend for Adlai Nortye's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye DeferredTaxAndRevenue Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
- - - 5.00

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only - - - - 5.00

Adlai Nortye DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adlai Nortye Business Description

Traded in Other Exchanges
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.